Page last updated: 2024-11-12
cypate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Cypate: a fluorescent dye; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10963571 |
CHEMBL ID | 2071606 |
MeSH ID | M000614051 |
Synonyms (8)
Synonym |
---|
cypate |
CHEMBL2071606 |
GRAVJJAQKJDGPM-UHFFFAOYSA-N |
3-[(2e)-2-[(2e,4e,6e)-7-[3-(2-carboxyethyl)-1,1-dimethylbenzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]propanoic acid;bromide |
95837-47-1 |
EX-A4740 |
E86095 |
317809-26-0 |
Research Excerpts
Overview
Cypate is an organic material with tumor treatment function, which has photothermal effect.
Excerpt | Reference | Relevance |
---|---|---|
"Cypate is an organic material with tumor treatment function, which has photothermal effect. " | ( Preparation of Composite Cypate Nanoparticles and Its Application in the Treatment of Pediatric Bladder Tumors. Bai, B; Chen, W; Lei, Y; Li, Z; Ma, H; Tao, H; Wang, L; Yang, P; Zhang, N, 2021) | 2.37 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID678143 | Binding affinity to integrin alphavbeta3 in human A549 cells assessed as cellular uptake after 1 hr by NIR Fluorescence microscopy analysis | 2012 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17 | Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging. |
AID678144 | Binding affinity to integrin alphavbeta3 in human A549 cells assessed as cellular uptake after 6 hrs by NIR Fluorescence microscopy analysis | 2012 | Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17 | Near-infrared fluorescent divalent RGD ligand for integrin αvβ₃-targeted optical imaging. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (24)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 16 (66.67) | 24.3611 |
2020's | 8 (33.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.06) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 24 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |